Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Tyra Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 46 | 51 | +5 |
| Shares | 35.2M | 35.7M | +414.5K (+1.2%) |
| Value | $267.8M | $573.0M | +$305.1M (+113.9%) |
New holders (10)
Institutions that held Tyra Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Driehaus Capital Management LLC | 134,173 | $2.16M | 0.03% |
| Ikarian Capital, LLC | 48,170 | $774.1K | 0.32% |
| Artia Global Partners LP | 45,253 | $727.2K | 0.29% |
| Victory Capital Management Inc | 33,760 | $542.5K | 0.00% |
| Mariner, LLC | 21,529 | $346.0K | 0.00% |
| Millennium Management LLC | 13,475 | $217.0K | 0.00% |
| MetLife Investment Management | 7,702 | $123.8K | 0.00% |
| Wells Fargo & Company | 2,362 | $38.0K | 0.00% |
| Metropolitan Life Insurance Co | 814 | $13.1K | 0.00% |
| Federated Hermes, Inc. | 54 | $868 | 0.00% |
Sold out (5)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Sio Capital Management, LLC | 152,159 | $1.16M |
| D. E. Shaw & Co., Inc. | 33,005 | $250.8K |
| Citadel Advisors LLC | 26,717 | $203.0K |
| Citigroup Inc | 89 | $676 |
| Credit Suisse AG | 1 | $8 |